Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > Not so serious
View:
Post by biodelatech on Jun 24, 2010 12:47am

Not so serious

The Fda says:
This meeting has been cancelled to allow time for the
resolution of several outstanding issues. The agency intends to continue
evaluating NDA 22340 and, as needed, may schedule an advisory committee meeting
in the future.
https://www.federalregister.gov/OFRUpload/OFRData/2010-15352_PI.pdf
What does it mean?
If they the issues another meeting will be scheduled.
There's nothing sinister about that.
Maybe fast-track has been too fast for Lux to get everything right.
If there were major flaws the FDA could have simply rejected the NDA .
But the FDA simply grants more time for the resolution of issues.
That has happened many times before.
Comment by biodelatech on Jun 24, 2010 12:53am
The Fda says: This meeting has been cancelled to allow time for the resolution of several outstanding issues. The agency intends to continue evaluating NDA 22340 and, as needed, may schedule an advisory committee meeting in the future. https://www.federalregister.gov/OFRUpload/OFRData/2010-15352_PI.pdf What does it mean? If Lux resolves the issues another meeting will be scheduled. There ...more  
Comment by labumba on Jun 24, 2010 1:06am
I agree that the issues are not seriuos type and can be resolved timely....thats why ISA didn't know all the way and Lux was not aware of ( ? )....now Lux wants an action letter to confrim the issues with FDA..if it is a drug safety issue, the NDA could have been rejected.....all the trials indicated the drug is good
Comment by macbethorfaust on Jun 24, 2010 10:55am
we have no idea frankly if the issues are serious or not or, more to the point, how long it will take to resolve them - what if another study is required?  then we are toastthat said, I am rather relucantly back in - same number of shares as before but pulled out some cash so maybe will be a slight postive in the end - and the market doesn't seem to think that it was as bad as I did so ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities